With a focus on women and minorities, the New York City-based Icahn School of Medicine at Mount Sinai announced plans to study survival rates and quality of life of patients who undergo various coronary revascularization procedures, according to a July 25 news release.
The Patient-Centered Outcomes Research Institute is funding the trial; $29.9 million was awarded to Mount Sinai and Weill Cornell Medicine. The study, which will enroll about 1,200 patients at 45 sites across the U.S. and Canada, is set to be conducted in phases and will begin in October.
Many trials comparing procedures including coronary artery bypass graft surgery and percutaneous coronary intervention have focused on white men.
"There is a great need to generate high-quality evidence to guide clinical decision-making for such procedures in women and minority groups who have been underrepresented in most prior studies," said Gregg Stone, MD, director of academic affairs for the Mount Sinai Health System and cardiology professor of medicine and population health science and policy at the medical school.